Real-World Prevalence of PD-L1 Expression in Chinese Patients with Advanced or Metastatic NSCLC: Express II Study

被引：0
|
作者：
Lin, D. [1 ]
Yang, X. [1 ]
Jiang, L. [2 ]
Wang, W. [2 ]
Hou, Y. [3 ]
Li, Y. [4 ]
Jin, Y. [4 ]
Fan, X. [5 ]
Sun, W. [6 ]
Yun, J. [7 ]
Li, P. [7 ]
Kuang, D. [8 ]
Zhang, L. [9 ]
Ni, J. [10 ]
Mao, A. [11 ]
Tang, W. [11 ]
Liu, Z. [11 ]
Wang, J. [11 ]
Xiao, S. [11 ]
机构：
[1] Beijing Canc Hosp, Beijing, Peoples R China
[2] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai, Peoples R China
[5] Nanjing Drum Tower Hosp, Nanjing, Peoples R China
[6] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[7] Sun Yat Sen, Canc Hosp, Guangzhou, Peoples R China
[8] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Shanghai, Peoples R China
[9] Shanghai Pulm Hosp, Shanghai, Peoples R China
[10] First Hosp Jilin Univ, Eastern Div, Changchun, Peoples R China
[11] Bldg A,Headquarters Pk Phase 2,1582 Gumei Rd, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Non-small cell lung cancer; programmed death-ligand 1; IHC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P33.12
引用
收藏
页码：S410 / S410
页数：1
相关论文
共 50 条
  • [41] A Chinese multicenter, real-world study of PD-L1 inhibitors in extensive stage small cell lung cancer
    Peng, J.
    Meng, R.
    Liu, X.
    Zhang, L.
    Wang, L.
    Feng, R.
    Feng, H.
    Huang, Z.
    Yao, D.
    Li, X.
    Liu, N.
    Tan, B.
    Li, S.
    Yu, J.
    Meng, X.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S135 - S135
  • [42] Clinical significance of inter-assay discrepancy in PD-L1 expression evaluation for the efficacy of pembrolizumab in advanced NSCLC patients with high PD-L1 expression
    Miyakoshi, Jun
    Kashima, Jumpei
    Shirasawa, Masayuki
    Torasawa, Masahiro
    Matsumoto, Yuji
    Masuda, Ken
    Shinno, Yuki
    Okuma, Yusuke
    Yoshida, Tatsuya
    Goto, Yasushi
    Horinouchi, Hidehito
    Shiraishi, Kouya
    Kohno, Takashi
    Yamamoto, Noboru
    Yatabe, Yasushi
    Ohe, Yuichiro
    CANCER RESEARCH, 2024, 84 (06)
  • [43] Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC
    John, Nikolaus
    Schlintl, Verena
    Sassmann, Teresa
    Lindenmann, Joerg
    Fediuk, Melanie
    Wurm, Robert
    Douschan, Philipp
    Zacharias, Martin
    Kalson, Lipika
    Posch, Florian
    Absenger, Gudrun
    Brcic, Luka
    Jost, Philipp J.
    Terbuch, Angelika
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [44] Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection
    Wasilewski, David
    Onken, Julia
    Hoericke, Paul
    Bukatz, Jan
    Murad, Selin
    Frueh, Anton
    Shaked, Zoe
    Misch, Martin
    Kuehl, Anja
    Klein, Oliver
    Ehret, Felix
    Kaul, David
    Radbruch, Helena
    Capper, David
    Vajkoczy, Peter
    Horst, David
    Frost, Nikolaj
    Bischoff, Philip
    JOURNAL OF NEURO-ONCOLOGY, 2024, 167 (01) : 155 - 167
  • [45] Immune-Related Adverse Events and their Association with Effectiveness of PD-1/PD-L1 Inhibitors in NSCLC: A Real-World Study from China
    Chen, X.
    Fang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S303 - S303
  • [46] PREDICTIVE ROLE OF INTRACRANIAL PD-L1 EXPRESSION IN A REAL-WORLD COHORT OF NSCLC PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITION FOLLOWING BRAIN METASTASIS RESECTION
    Murad, S.
    Wasilewski, D.
    Onken, J.
    Hoericke, P.
    Bukatz, J.
    Frueh, A.
    Shaked, Z.
    Misch, M.
    Kuehl, A.
    Klein, O.
    Ehret, F.
    Kaul, D.
    Radbruch, H.
    Capper, D.
    Vajkoczy, P.
    Horst, D.
    Frost, N.
    Bischoff, P.
    NEURO-ONCOLOGY, 2024, 26
  • [47] Predictive role of intracranial PD-L1 expression in a real-world cohort of NSCLC patients treated with immune checkpoint inhibition following brain metastasis resection
    David Wasilewski
    Julia Onken
    Paul Höricke
    Jan Bukatz
    Selin Murad
    Anton Früh
    Zoe Shaked
    Martin Misch
    Anja Kühl
    Oliver Klein
    Felix Ehret
    David Kaul
    Helena Radbruch
    David Capper
    Peter Vajkoczy
    David Horst
    Nikolaj Frost
    Philip Bischoff
    Journal of Neuro-Oncology, 2024, 167 : 155 - 167
  • [48] Study on the Expression Levels and Clinical Significance of PD-1 and PD-L1 in Plasma of NSCLC Patients
    He, Jiabei
    Pan, Yuanqing
    Guo, Yang
    Li, Baolan
    Tang, Yu
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (05) : 156 - 164
  • [49] Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes
    Cortellini, Alessio
    Friedlaender, Alex
    Banna, Giuseppe L.
    Porzio, Giampiero
    Bersanelli, Melissa
    Cappuzzo, Federico
    Aerts, Joachim G. J., V
    Giusti, Raffaele
    Bria, Emilio
    Cortinovis, Diego
    Grossi, Francesco
    Migliorino, Maria R.
    Galetta, Domenico
    Passiglia, Francesco
    Berardi, Rossana
    Mazzoni, Francesca
    Di Noia, Vincenzo
    Signorelli, Diego
    Tuzi, Alessandro
    Gelibter, Alain
    Marchetti, Paolo
    Macerelli, Marianna
    Rastelli, Francesca
    Chiari, Rita
    Rocco, Danilo
    Inno, Alessandro
    Di Marino, Pietro
    Mansueto, Giovanni
    Zoratto, Federica
    Santoni, Matteo
    Tudini, Marianna
    Ghidini, Michele
    Filetti, Marco
    Catino, Annamaria
    Pizzutilo, Pamela
    Sala, Luca
    Occhipinti, Mario Alberto
    Citarella, Fabrizio
    Marco, Russano
    Torniai, Mariangela
    Cantini, Luca
    Follador, Alessandro
    Sforza, Vincenzo
    Nigro, Olga
    Ferrara, Miriam G.
    D'Argento, Ettore
    Leonetti, Alessandro
    Pettoruti, Linda
    Antonuzzo, Lorenzo
    Scodes, Simona
    CLINICAL LUNG CANCER, 2020, 21 (06) : 498 - +
  • [50] Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
    Zhang, Jie
    Gao, Jing
    Li, Yanyan
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Chen, Xiaoling
    Han, Jindi
    Ma, Xiangjuan
    Tian, Guangming
    Wu, Di
    Shen, Lin
    Fang, Jian
    THORACIC CANCER, 2015, 6 (04) : 534 - 538
12345